Decision

Apotex Inc. v. Allergan Inc., T-820-13 (Brimonidine*)

Associate Justice Aalto - 2014-10-24

Read full decision. Summary prepared by Alan Macek:

The Prothonotary denied the request for particulars of certain paragraphs of the Statement of Defence and Counterclaim on the basis that the paragraphs were "a simple traverse of Apotex's position and Apotex requires nothing in the way particulars to respond". The paragraphs at issue related to obviousness, inventive concept, sound prediction, and utility.

Decision relates to:

 

Canadian Intellectual Property